• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Medical Devices

  • Print
  • Share
  • E-mail
-

Presentation: 510(k) Third Party Reviews

(This presentation is also available in video format with captioning and PDF printer-friendly format.)

Eric Rechen
Policy Analyst Program Operations Staff
FDA Office of Device Evaluation
CDRH
 

Third Party Review Program(a.k.a. “Accredited Persons Program”)

  • Gives 510(k) submitters the option of using accredited, non-Federal organizations to review 510(k)s for low and moderate risk devices, in place of FDA’s review
  • Authorized by §523 of the FD&C Act
     

Purpose

  • More rapid decisions
  • Better allocationof FDA’s resources

Comparison of Average Total Elapsed Days for 510(k) Reviews- Excluding “Special” 510(k)s -(FY 2005 Receipts)

Bar graph. For devices with guidance, 510(k)s reviewed by FDA took 86 total days, and third party reviews took 70 days. For devices without guidance, 510(k)s reviewed by FDA took 126 total days, and t

Use of Third Parties

  • Approximately 300 “third party” 510(k)s in FY 2008
  • 8% of all 510(k)s
     

How Does It Work?

Third Party (TP) Review Process

  • Applicant may elect to use TP or FDA for eligible devices
     
  • If TP route is chosen:
    Applicant contracts with TP
    • TP reviews 510(k), makes recom.
       
    • FDA issues final decision (30 days)

FDA’s Third Party Web Page 

Procedural guidance

  • List of eligible devices
  • List of Accredited Persons

Which Devices Are Eligible?

Eligible Devices

  • More than 670 eligible Class I and Class II device types
  • 60% of all 510(k) submissions
  • Eligible device list
     

Statutory Limitation§ 523(a)(3)

Third parties may not review:

  • Class III devices
  • Class II devices that:
    • are permanently implantable
    • are life sustaining/supporting, or
    • require clinical data in 510(k)s

Statutory Limitation§ 523(a)(3)

Third parties also may not review:

  • 510(k)s that require CBER/CDER lead or consulting review. Example:
    (e.g., drug/device combination products)

Who Are the Third Parties?

Accredited Organizations

  • British Standards Institution (United Kingdom)
  • Center for Measurement Standards, ITRI (Taiwan)
  • Cheiroon, BV (Netherlands)
  • CITECH
  • Intertek Testing Services
  • KEMA Quality, BV (Netherlands)
  • NIOM Scand. Inst. of Dental Materials (Norway)
  • Regulatory Technology Services, LLC
  • TUV SUD America, Inc.
  • TUV Rheinland of North America, Inc.
  • Underwriters Laboratories, Inc.

Accreditation of Third Parties

  • FDA serves as accreditation body
     
  • Emphasis is on adequacy of:
  • Personnel and procedures to ensure competent reviews
    • Controls to prevent conflict of interest

Why Consider a Third Party?

  • Usually more timely
  • Many TPs also have standards expertise and foreign regulatory role
  • Accessibility
  • No FDA user fee

When to Think Twice

  • Complex, precedent-setting submissions
  • Device eligibility uncertain
    (e.g., may require clinical data)
  • “Special” 510(k)s
  • TP lacks relevant experience

Questions?

-
-